| Humoral and T-cell response to SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab L Brill, A Rechtman, O Zveik, N Haham, E Oiknine-Djian, DG Wolf, N Levin, ... JAMA neurology 78 (12), 1510-1514, 2021 | 156 | 2021 |
| Description of 3 patients with myasthenia gravis and COVID-19 N Rein, N Haham, E Orenbuch-Harroch, M Romain, Z Argov, ... Journal of the Neurological Sciences 417, 117053, 2020 | 54 | 2020 |
| Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells O Zveik, N Fainstein, A Rechtman, N Haham, T Ganz, I Lavon, L Brill, ... Glia 70 (6), 1191-1209, 2022 | 22 | 2022 |
| Volumetric brain loss correlates with a relapsing MOGAD disease course A Rechtman, L Brill, O Zveik, B Uliel, N Haham, AS Bick, N Levin, ... Frontiers in Neurology 13, 867190, 2022 | 19 | 2022 |
| Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis L Brill, A Rechtman, O Zveik, N Haham, N Levin, A Shifrin, A Rozenberg, ... Multiple Sclerosis and Related Disorders 57, 103343, 2022 | 18 | 2022 |
| IL-6 as a marker for NMOSD disease activity A Haramati, A Rechtman, O Zveik, N Haham, L Brill, A Vaknin-Dembinsky Journal of Neuroimmunology 370, 577925, 2022 | 11 | 2022 |
| Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine L Brill, A Rechtman, A Shifrin, A Rozenberg, S Afanasiev, O Zveik, ... Multiple Sclerosis and Related Disorders 63, 103863, 2022 | 7 | 2022 |
| COVID-19 in Cladribine-treated patient with multiple sclerosis N Haham, A Vaknin-Dembinsky Journal of Neuroimmunology 359, 577690, 2021 | 6 | 2021 |
| MIF-173G/C polymorphism is associated with NMO disease severity L Brill, A Vaknin-Dembinsky, O Zveik, N Haham, K Miller, G Benedek Journal of Neuroimmunology 339, 577120, 2020 | 5 | 2020 |
| Sera of neuromyelitis optica patients increase BID-mediated apoptosis in astrocytes O Zveik, A Rechtman, N Haham, I Adini, T Canello, I Lavon, L Brill, ... International Journal of Molecular Sciences 23 (13), 7117, 2022 | 4 | 2022 |
| Effect of cladribine on COVID-19 serology responses following 2 doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis L Brill, A Rechtman, O Zveik, N Haham, N Levin, A Shifrin, A Rozenberg, ... MULTIPLE SCLEROSIS JOURNAL 27 (2_ SUPPL), 647-648, 2021 | 2 | 2021 |
| Thyroid hormone dysfunction in MOGAD and other demyelinating diseases A Rechtman, O Zveik, N Haham, T Freidman-Korn, A Vaknin-Dembinsky Journal of the Neurological Sciences 457, 122866, 2024 | 1 | 2024 |
| A protective effect of lower MHC-II expression in MOGAD A Rechtman, O Zveik, N Haham, L Brill, A Vaknin-Dembinsky Journal of Neuroimmunology 391, 578351, 2024 | | 2024 |
| Altered immune co-inhibitory receptor expression and correlation of LAG-3 expression to disease severity in NMOSD N Haham, O Zveik, A Rechtman, L Brill, A Vaknin-Dembinsky Journal of Neuroimmunology 388, 578289, 2024 | | 2024 |
| Brain MRI activity during the year before pregnancy can predict long-term clinical worsening in patients with Multiple Sclerosis S Kahila, O Zveik, N Levin, L Brill, A Rechtman, N Haham, T Imbar, ... Neurological Sciences 44 (11), 3989-3996, 2023 | | 2023 |
| Volumetric Differences in MOGAD and NMOSD A Rechtman, O Zveik, N Haham, L Brill, AV Dembinsky MULTIPLE SCLEROSIS JOURNAL 29, 538-538, 2023 | | 2023 |
| White Blood Cell Count Profile in MOGAD and Related Demyelinating Disorders A Rechtman, O Zveik, N Haham, L Brill, N Levin MULTIPLE SCLEROSIS JOURNAL 29, 156-156, 2023 | | 2023 |
| Brain MRI Activity During the Year Before Pregnancy Can Predict Long-Term Clinical Worsening in Patients with Multiple Sclerosis (P11-3.018) O Zveik, S Kahila, N Levin, A Rechtmen, N Haham, A Vaknin-Dembinsky Neurology 100 (17_supplement_2), 1723, 2023 | | 2023 |
| Short and long-term serology response of MS patients treated with natalizumab following two doses of mRNA COVID-19 vaccine (Pfizer) L Brill, A Rechtman, A Shifrin, A Rozenberg, S Afanasiev, O Zveik, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 871-871, 2022 | | 2022 |
| IL-6 as a Blood Biomarker in NMOSD patients: a positive correlation between clinical status and imaging to IL-6 serum levels A Haramati, A Rehctman, O Zveik, N Haham, L Brill, A Vaknin-Dembinsky MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 751-751, 2022 | | 2022 |
